|
US3686398A
(en)
|
1970-07-20 |
1972-08-22 |
Chevron Res |
10,9-boroxarophenanthrene as fungicides
|
|
US4194047A
(en)
|
1975-11-21 |
1980-03-18 |
Merck & Co., Inc. |
Substituted N-methylene derivatives of thienamycin
|
|
US4260543A
(en)
|
1978-07-03 |
1981-04-07 |
Merck & Co., Inc. |
Crystalline N-formimidoyl thienamycin
|
|
US4409214A
(en)
|
1979-11-19 |
1983-10-11 |
Fujisawa Pharmaceutical, Co., Ltd. |
7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
|
|
US4353807A
(en)
|
1981-03-24 |
1982-10-12 |
Mobil Oil Corporation |
Lubricants and fuels containing boroxarophenanthrene compounds
|
|
FR2573070B1
(fr)
|
1984-11-13 |
1987-01-30 |
Rhone Poulenc Sante |
Procede de preparation de composes carbonyles
|
|
US4783443A
(en)
|
1986-03-03 |
1988-11-08 |
The University Of Chicago |
Amino acyl cephalosporin derivatives
|
|
CA1283404C
(en)
|
1986-07-01 |
1991-04-23 |
Shigeru Sanai |
Cephalosporin compounds, processes for their preparation and antibacterial agents
|
|
ZA893284B
(en)
|
1988-05-04 |
1990-03-28 |
Igen Inc |
Peptide analogs and their use as haptens to elicit catalytic antibodies
|
|
US5442100A
(en)
|
1992-08-14 |
1995-08-15 |
The Procter & Gamble Company |
β-aminoalkyl and β-N-peptidylaminoalkyl boronic acids
|
|
US5888998A
(en)
|
1997-04-24 |
1999-03-30 |
Synphar Laboratories, Inc. |
2-oxo-1-azetidine sulfonic acid derivatives as potent β-lactamase inhibitors
|
|
US6184363B1
(en)
|
1997-06-13 |
2001-02-06 |
Northwestern University |
Inhibitors of β-lactamases and uses therefor
|
|
WO1998056392A1
(en)
|
1997-06-13 |
1998-12-17 |
Northwestern University |
INHIBITORS OF β-LACTAMASES AND USES THEREFOR
|
|
AU3124300A
(en)
|
1998-12-16 |
2000-07-03 |
Northwestern University |
Inhibitors of beta-lactamases and uses therefor
|
|
AU2190400A
(en)
|
1998-12-16 |
2000-07-03 |
Northwestern University |
Inhibitors of beta-lactamases and uses therefor
|
|
MXPA02003175A
(es)
|
1999-09-25 |
2002-09-30 |
Smithkline Beecham Plc |
Derivados de piperazina como antagonsitas de 5-ht1b.
|
|
WO2001030149A1
(en)
|
1999-10-28 |
2001-05-03 |
Merck & Co., Inc. |
Novel succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
|
|
AU2001292732A1
(en)
|
2000-09-12 |
2002-03-26 |
Larry C. Blasczcak |
Beta-lactam analogs and uses therefor
|
|
US6916803B2
(en)
|
2000-09-14 |
2005-07-12 |
Pantherix, Ltd. |
3-(Heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents
|
|
AU2002243508A1
(en)
|
2001-01-10 |
2002-07-24 |
Bristol-Myers Squibb Company Patent Department |
Alpha-aminoboronic acids prepared by novel synthetic methods
|
|
DE10118698A1
(de)
|
2001-04-17 |
2002-11-07 |
Jerini Ag |
Verfahren zur Immobilisierung und damit hergestellte Anordnungen von Verbindungen auf einer planaren Oberfläche
|
|
AU2002360732A1
(en)
|
2001-12-26 |
2003-07-24 |
Guilford Pharmaceuticals |
Change inhibitors of dipeptidyl peptidase iv
|
|
FR2835186B1
(fr)
|
2002-01-28 |
2006-10-20 |
Aventis Pharma Sa |
Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
|
|
JP2003229277A
(ja)
|
2002-02-04 |
2003-08-15 |
Matsushita Electric Ind Co Ltd |
発光素子材料およびそれを用いた発光素子並びに装置
|
|
AUPS065102A0
(en)
|
2002-02-20 |
2002-03-14 |
Unisearch Limited |
Fluorous acetalation
|
|
CN100528846C
(zh)
|
2002-09-11 |
2009-08-19 |
株式会社吴羽 |
胺化合物及其用途
|
|
EP2325223B1
(en)
|
2002-10-30 |
2014-05-14 |
Sumitomo Chemical Company, Limited |
Complex aryl copolymer compounds and polymer light emitting devices made by using the same
|
|
US7439253B2
(en)
|
2002-12-06 |
2008-10-21 |
Novexel |
Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
|
|
US7271186B1
(en)
|
2002-12-09 |
2007-09-18 |
Northwestern University |
Nanomolar β-lactamase inhibitors
|
|
JP2006511587A
(ja)
|
2002-12-20 |
2006-04-06 |
ミジェニックス コーポレイション |
アデニンヌクレオチドトランスロカーゼ（ａｎｔ）リガンドならびにそれに関連する組成物および方法
|
|
TW200418791A
(en)
|
2003-01-23 |
2004-10-01 |
Bristol Myers Squibb Co |
Pharmaceutical compositions for inhibiting proteasome
|
|
JP4233365B2
(ja)
|
2003-03-25 |
2009-03-04 |
三井化学株式会社 |
アザジオール錯体化合物、及び該化合物を用いる光記録媒体
|
|
US7842941B2
(en)
|
2003-10-06 |
2010-11-30 |
Sumitomo Chemical Company, Limited |
Aromatic compound
|
|
CA2541832C
(en)
|
2003-10-10 |
2009-11-24 |
Pfizer Products Inc. |
Substituted 2h-[1,2,4]triazolo[4,3-a]pyrazines as gsk-3 inhibitors
|
|
NZ547752A
(en)
|
2003-11-12 |
2009-12-24 |
Phenomix Corp |
Heterocyclic boronic acid compounds for inhibiting dipeptidyl peptidase-IV
|
|
TW200600494A
(en)
|
2004-03-08 |
2006-01-01 |
Chugai Pharmaceutical Co Ltd |
Bisphenyl compounds useful as vitamin d3 receptor agonists
|
|
US20060019116A1
(en)
|
2004-07-22 |
2006-01-26 |
Eastman Kodak Company |
White electroluminescent device with anthracene derivative host
|
|
TW200618820A
(en)
|
2004-11-05 |
2006-06-16 |
Alza Corp |
Liposome formulations of boronic acid compounds
|
|
US20060178357A1
(en)
|
2005-02-10 |
2006-08-10 |
Buynak John D |
Chphalosporin-derived mercaptans as inhibitors of serine and metallo-beta-lactamases
|
|
NZ578297A
(en)
|
2005-02-16 |
2010-11-26 |
Anacor Pharmaceuticals Inc |
Boron-containing small molecules
|
|
KR101020024B1
(ko)
|
2005-02-22 |
2011-03-09 |
테바 파마슈티컬 인더스트리즈 리미티드 |
로수바스타틴 알킬에테르를 함유하지 않는 로수바스타틴 및이의 염 및 이의 제조 방법
|
|
US9184428B2
(en)
|
2005-03-15 |
2015-11-10 |
Uchicago Argonne Llc |
Non-aqueous electrolytes for lithium ion batteries
|
|
US7825139B2
(en)
|
2005-05-25 |
2010-11-02 |
Forest Laboratories Holdings Limited (BM) |
Compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
|
TW200734311A
(en)
|
2005-11-21 |
2007-09-16 |
Astrazeneca Ab |
New compounds
|
|
WO2007065288A2
(en)
|
2005-12-07 |
2007-06-14 |
Basilea Pharmaceutica Ag |
Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
|
|
ME02188B
(me)
|
2006-02-16 |
2016-02-20 |
Anacor Pharmaceuticals Inc |
Mali molekuli koji sadrže boron kao antiinflamatorni agensi
|
|
EP2069347A2
(en)
|
2006-09-27 |
2009-06-17 |
Merck & Co., Inc. |
Novel inhibitors of beta-lactamase
|
|
EP2124942B1
(en)
|
2007-03-23 |
2016-04-27 |
Basilea Pharmaceutica AG |
Combination medicaments for treating bacterial infections
|
|
GB0719366D0
(en)
|
2007-10-03 |
2007-11-14 |
Smithkline Beecham Corp |
Compounds
|
|
US20100120715A1
(en)
|
2007-11-13 |
2010-05-13 |
Burns Christopher J |
Beta-lactamase inhibitors
|
|
CA2705393A1
(en)
|
2007-11-13 |
2009-05-22 |
Protez Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
|
WO2009091856A2
(en)
|
2008-01-18 |
2009-07-23 |
Merck & Co., Inc. |
Beta-lactamase inhibitors
|
|
US8129398B2
(en)
|
2008-03-19 |
2012-03-06 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
|
WO2009140309A2
(en)
|
2008-05-12 |
2009-11-19 |
Anacor Pharmaceuticals, Inc. |
Boron-containing small molecules
|
|
US20110124634A1
(en)
|
2008-05-13 |
2011-05-26 |
Poniard Pharmaceuticals, Inc. |
Bioactive compounds for treatment of cancer and neurodegenerative diseases
|
|
US20120046242A1
(en)
|
2008-12-24 |
2012-02-23 |
Massachusetts Institute Of Technology |
Molecular activators of the wnt/beta-catenin pathway
|
|
WO2010097675A1
(en)
|
2009-02-27 |
2010-09-02 |
Dhanuka Laboratories Ltd. |
An improved preparation process for cefpodoxime proxetil
|
|
WO2010104818A1
(en)
|
2009-03-09 |
2010-09-16 |
Bristol-Myers Squibb Company |
Aza pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists
|
|
US20100292185A1
(en)
|
2009-05-12 |
2010-11-18 |
Burns Christopher J |
Beta-lactamase inhibitors
|
|
KR101460095B1
(ko)
|
2009-06-08 |
2014-11-10 |
캘리포니아 캐피탈 에쿼티, 엘엘씨 |
트리아진 유도체와 이들의 치료적 용도
|
|
WO2011017125A1
(en)
|
2009-07-28 |
2011-02-10 |
Anacor Pharmaceuticals, Inc. |
Trisubstituted boron-containing molecules
|
|
US20120329770A1
(en)
|
2010-02-26 |
2012-12-27 |
Gary Igor Dmitrienko |
Cephalosporin derivatives useful as beta-lactamase inhibitors and compositions and methods of use thereof
|
|
US8513218B2
(en)
|
2010-03-31 |
2013-08-20 |
Millennium Pharmaceuticals, Inc. |
Derivatives of 1-amino-2-cyclopropylethylboronic acid
|
|
US20110288063A1
(en)
|
2010-05-19 |
2011-11-24 |
Naeja Pharmaceutical Inc. |
Novel fused bridged bicyclic heteroaryl substituted 6-alkylidene penems as potent beta-lactamase inhibitors
|
|
JP5603487B2
(ja)
|
2010-06-10 |
2014-10-08 |
テクニオン リサーチ アンド ディベラップメント ファウンデイション リミテッド |
ヨウ化物の調製のためのプロセス
|
|
CA2807546C
(en)
|
2010-08-10 |
2022-08-23 |
Rempex Pharmaceuticals, Inc. |
Cyclic boronic acid ester derivatives and therapeutic uses thereof
|
|
DK2632927T3
(en)
|
2010-10-26 |
2016-04-11 |
Mars Inc |
Boronates AS ARGINSASEINHIBITORER
|
|
WO2012067664A1
(en)
|
2010-11-18 |
2012-05-24 |
Glaxo Group Limited |
Compounds
|
|
EP2487159A1
(en)
|
2011-02-11 |
2012-08-15 |
MSD Oss B.V. |
RorgammaT inhibitors
|
|
EP2508506A1
(en)
|
2011-04-08 |
2012-10-10 |
LEK Pharmaceuticals d.d. |
Preparation of sitagliptin intermediates
|
|
CN102320960A
(zh)
|
2011-08-02 |
2012-01-18 |
安徽东健化工科技有限公司 |
一种6-氟水杨酸的制备方法
|
|
WO2013033461A1
(en)
|
2011-08-31 |
2013-03-07 |
Rempex Pharmaceuticals, Inc. |
Heterocyclic boronic acid ester derivatives and therapeutic uses thereof
|
|
WO2013053372A1
(en)
|
2011-10-13 |
2013-04-18 |
Therabor Pharmaceuticals |
Boronic acid inhibitors of beta-lactamases
|
|
WO2013056163A1
(en)
|
2011-10-14 |
2013-04-18 |
The Regents Of The University Of California |
Beta-lactamase inhibitors
|
|
SG11201403254QA
(en)
|
2011-12-22 |
2014-07-30 |
Ares Trading Sa |
Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors
|
|
US20150018311A1
(en)
|
2012-01-09 |
2015-01-15 |
University of Tromsø |
Therapeutic boron-containing compounds
|
|
EP2615080A1
(en)
|
2012-01-12 |
2013-07-17 |
LEK Pharmaceuticals d.d. |
Preparation of Optically Pure ß-Amino Acid Type Active Pharmaceutical Ingredients and Intermediates thereof
|
|
EP2814483A2
(en)
|
2012-02-15 |
2014-12-24 |
Rempex Pharmaceuticals, Inc. |
Methods of treating bacterial infections
|
|
US9156858B2
(en)
|
2012-05-23 |
2015-10-13 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
US10561675B2
(en)
|
2012-06-06 |
2020-02-18 |
Rempex Pharmaceuticals, Inc. |
Cyclic boronic acid ester derivatives and therapeutic uses thereof
|
|
AU2013355110B2
(en)
|
2012-12-07 |
2017-11-09 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
|
KR20150103269A
(ko)
|
2013-01-04 |
2015-09-09 |
렘펙스 파머수티클스 인코퍼레이티드 |
보론산 유도체 및 그의 치료적 용도
|
|
MX2015008627A
(es)
|
2013-01-04 |
2015-09-23 |
Rempex Pharmaceuticals Inc |
Derivados de acido boronico y usos terapeuticos de los mismos.
|
|
US9241947B2
(en)
|
2013-01-04 |
2016-01-26 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
US9101638B2
(en)
|
2013-01-04 |
2015-08-11 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
EP2943204B1
(en)
|
2013-01-10 |
2019-03-13 |
Venatorx Pharmaceuticals Inc |
Beta-lactamase inhibitors
|
|
EP2970340B1
(en)
|
2013-03-14 |
2020-02-12 |
Venatorx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
|
ES2683329T3
(es)
|
2013-03-15 |
2018-09-26 |
Intrexon Corporation |
Diacilhidrazinas que contienen boro
|
|
EP3139930B1
(en)
|
2014-05-05 |
2024-08-14 |
Melinta Therapeutics, Inc. |
Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof
|
|
ES2750805T3
(es)
|
2014-05-05 |
2020-03-27 |
Rempex Pharmaceuticals Inc |
Síntesis de sales de boronato y usos de las mismas
|
|
AU2015264418A1
(en)
|
2014-05-19 |
2016-11-10 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
WO2015191907A1
(en)
|
2014-06-11 |
2015-12-17 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
|
US9511142B2
(en)
|
2014-06-11 |
2016-12-06 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
|
WO2016003929A1
(en)
|
2014-07-01 |
2016-01-07 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
WO2016065282A1
(en)
|
2014-10-24 |
2016-04-28 |
The Regents Of The University Of Michigan |
Nasal formulation, nasal kit, and method for enhancing nasal nitric oxide (no) levels
|
|
US10662205B2
(en)
|
2014-11-18 |
2020-05-26 |
Qpex Biopharma, Inc. |
Cyclic boronic acid ester derivatives and therapeutic uses thereof
|
|
US20170252351A1
(en)
|
2015-01-24 |
2017-09-07 |
Wockhardt Limited |
Antibacterial Compositions
|
|
US20180051041A1
(en)
|
2015-03-17 |
2018-02-22 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
WO2016172208A1
(en)
|
2015-04-24 |
2016-10-27 |
Rempex Pharmaceuticals, Inc. |
Methods of treating bacterial infections
|
|
WO2017100537A1
(en)
|
2015-12-10 |
2017-06-15 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
|
MX389349B
(es)
|
2016-06-30 |
2025-03-20 |
Qpex Biopharma Inc |
Derivados de ácido borónico y usos terapéuticos de los mismos.
|
|
US10624899B2
(en)
|
2016-07-14 |
2020-04-21 |
Achaogen, Inc. |
Combination products for the treatment of bacterial infections and methods of producing or dosing of same
|
|
DK3512851T3
(en)
|
2016-09-16 |
2022-10-17 |
Entasis Therapeutics Ltd |
Beta-lactamase inhibitor compounds
|
|
US10085999B1
(en)
|
2017-05-10 |
2018-10-02 |
Arixa Pharmaceuticals, Inc. |
Beta-lactamase inhibitors and uses thereof
|
|
US11286270B2
(en)
|
2017-10-11 |
2022-03-29 |
Qpex Biopharma, Inc. |
Boronic acid derivatives and synthesis thereof
|
|
WO2019093450A1
(ja)
|
2017-11-10 |
2019-05-16 |
塩野義製薬株式会社 |
ジアザビシクロオクタン誘導体
|
|
EP3781576B1
(en)
*
|
2018-04-20 |
2024-06-12 |
Qpex Biopharma, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
BR112021010095A2
(pt)
|
2018-11-29 |
2021-09-28 |
VenatoRx Pharmaceuticals, Inc. |
Composições de combinação que compreendem um inibidor de beta-lactamase e usos das mesmas
|
|
EP3986419B1
(en)
|
2019-06-19 |
2025-05-14 |
Qpex Biopharma, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
CA3152300C
(en)
|
2019-08-29 |
2024-04-30 |
Arixa Pharmaceuticals, Inc. |
Orally administered combinations of beta lactam antibiotics and avibactam derivatives for treating bacterial infections
|